Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report

By Wang Sean  

Targeted Oncology, Vol. 5, Iss. 1, 2010-03 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study

By                          

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-01 ,pp. : 433-441

Spandidos Publications

Access to resources Recommend Favorite

Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report

By                      

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 50-52

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma

By                          

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 381-386

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib and locoregional deep electrohyperthermia in advanced hepatocellular carcinoma: A phase II study

By                    

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1783-1787

Spandidos Publications

Access to resources Recommend Favorite